BBusiness Read More JPM 2026: Novo Nordisk’s Jacob Peterson on the Future of Obesity TherapeuticsJanuary 23, 2026 Novo Nordisk is doubling down on obesity and diabetes. Speaking with Inside Precision Medicine at the 2026 J.P.…
GGenetics Read More Antisense Oligonucleotides Market Trends Report 2025-2035:October 1, 2025 Dublin, Oct. 01, 2025 (GLOBE NEWSWIRE) — The “Antisense Oligonucleotides Market Industry Trends and Global Forecasts to 2035:…